$2.15 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 113 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was 47.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARRY | Sell | ARRAY BIOPHARMA INC | $65,841,000 | +33.2% | 10,585,406 | -2.8% | 3.06% | +31.5% |
| PFE | Sell | PFIZER INC | $51,849,000 | -0.2% | 1,805,000 | -2.7% | 2.41% | -1.5% |
| AUXL | Sell | AUXILIUM PHARMACEUTICALS INC | $45,288,000 | -43.9% | 2,488,328 | -48.7% | 2.11% | -44.6% |
| KERX | Sell | KERYX BIOPHARMACEUTICALS INC | $38,839,000 | -11.3% | 3,849,296 | -34.4% | 1.81% | -12.5% |
| Sell | HOLOGIC INCdebt 2.000% 3/0 | $37,929,000 | -20.3% | 37,516,000 | -21.0% | 1.76% | -21.3% | |
| INFI | Sell | INFINITY PHARMACEUTICALS INC | $37,853,000 | -0.7% | 2,171,744 | -7.8% | 1.76% | -2.0% |
| CBST | Sell | CUBIST PHARMACEUTICALS INC | $35,207,000 | +4.9% | 554,000 | -20.3% | 1.64% | +3.5% |
| ATRS | Sell | ANTARES PHARMA INC | $35,132,000 | -10.2% | 8,653,119 | -7.9% | 1.63% | -11.3% |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDadr | $33,728,000 | -30.8% | 892,759 | -28.2% | 1.57% | -31.7% |
| Sell | EXELIXIS INCnote 4.250% 8/1 | $33,672,000 | -48.6% | 29,000,000 | -56.7% | 1.57% | -49.2% | |
| FRX | Sell | FOREST LABS INC | $31,879,000 | -17.7% | 745,000 | -21.2% | 1.48% | -18.8% |
| AIRM | Sell | AIR METHODS CORP | $28,966,000 | -1.6% | 680,561 | -21.7% | 1.35% | -2.9% |
| TRNX | Sell | TORNIER N V | $28,185,000 | -2.2% | 1,458,071 | -11.4% | 1.31% | -3.5% |
| ANGO | Sell | ANGIODYNAMICS INC | $26,573,000 | -11.2% | 2,013,104 | -24.1% | 1.24% | -12.3% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $24,526,000 | +14.0% | 383,158 | -44.8% | 1.14% | +12.5% |
| MRK | Sell | MERCK & CO INC NEW | $22,614,000 | -15.3% | 475,000 | -17.4% | 1.05% | -16.4% |
| ARIA | Sell | ARIAD PHARMACEUTICALS INC | $22,581,000 | +2.1% | 1,227,204 | -3.0% | 1.05% | +0.7% |
| UAM | Sell | UNIVERSAL AMERN CORP NEW | $22,297,000 | -18.2% | 2,926,100 | -4.5% | 1.04% | -19.2% |
| SGNT | Sell | SAGENT PHARMACEUTICALS INC | $20,703,000 | -52.6% | 1,014,863 | -51.3% | 0.96% | -53.2% |
| PCYC | Sell | PHARMACYCLICS INC | $17,563,000 | -2.7% | 127,030 | -44.0% | 0.82% | -3.9% |
| CAH | Sell | CARDINAL HEALTH INC | $16,949,000 | -48.7% | 325,000 | -53.6% | 0.79% | -49.4% |
| AGN | Sell | ALLERGAN INC | $16,729,000 | -47.1% | 184,955 | -50.7% | 0.78% | -47.8% |
| MOH | Sell | MOLINA HEALTHCARE INC | $16,340,000 | -22.9% | 459,000 | -19.5% | 0.76% | -23.9% |
| CEMP | Sell | CEMPRA INC | $9,240,000 | -26.0% | 803,516 | -50.0% | 0.43% | -26.9% |
| CCRN | Sell | CROSS CTRY HEALTHCARE INC | $8,115,000 | -0.6% | 1,343,464 | -15.1% | 0.38% | -2.1% |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $6,411,000 | -67.6% | 1,216,579 | -52.6% | 0.30% | -68.0% |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $3,822,000 | -57.8% | 1,067,726 | -60.6% | 0.18% | -58.3% |
| PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $3,195,000 | -75.3% | 119,448 | -77.4% | 0.15% | -75.6% |
| LCAV | Sell | LCA-VISION INC | $2,631,000 | +4.9% | 730,856 | -12.0% | 0.12% | +3.4% |
| DRTX | Sell | DURATA THERAPEUTICS INC | $2,495,000 | -53.9% | 275,979 | -63.3% | 0.12% | -54.5% |
| DSCO | Sell | DISCOVERY LABORATORIES INC N | $2,328,000 | +14.9% | 1,188,000 | -10.9% | 0.11% | +13.7% |
| DNDNQ | Sell | DENDREON CORPput | $2,051,000 | -80.1% | 700,000 | -72.0% | 0.10% | -80.4% |
| ELN | Sell | ELAN PLCadr | $1,558,000 | -33.2% | 100,000 | -39.4% | 0.07% | -34.5% |
| MSTX | Sell | MAST THERAPEUTICS INC | $1,156,000 | -31.8% | 2,634,221 | -33.3% | 0.05% | -32.5% |
| CTRX | Sell | CATAMARAN CORP | $574,000 | -60.8% | 12,500 | -58.3% | 0.03% | -60.9% |
| BONE | Sell | BACTERIN INTL HLDGS INC | $517,000 | -40.3% | 771,775 | -59.9% | 0.02% | -41.5% |
| AFAM | Exit | ALMOST FAMILY INC | $0 | – | -13,200 | -100.0% | -0.01% | – |
| ALKS | Exit | ALKERMES PLC | $0 | – | -11,000 | -100.0% | -0.02% | – |
| LHCG | Exit | LHC GROUP INC | $0 | – | -19,087 | -100.0% | -0.02% | – |
| MYGN | Exit | MYRIAD GENETICS INC | $0 | – | -18,777 | -100.0% | -0.02% | – |
| ILMN | Exit | ILLUMINA INC | $0 | – | -8,399 | -100.0% | -0.03% | – |
| WCRX | Exit | WARNER CHILCOTT PLC IRELAND | $0 | – | -34,543 | -100.0% | -0.03% | – |
| GTIV | Exit | GENTIVA HEALTH SERVICES INC | $0 | – | -77,839 | -100.0% | -0.04% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -35,000 | -100.0% | -0.08% | – |
| RAD | Exit | RITE AID CORP | $0 | – | -700,000 | -100.0% | -0.09% | – |
| MRGE | Exit | MERGE HEALTHCARE INC | $0 | – | -688,510 | -100.0% | -0.12% | – |
| AMED | Exit | AMEDISYS INC | $0 | – | -233,066 | -100.0% | -0.13% | – |
| Exit | MANNKIND CORPnote 5.750% 8/1 | $0 | – | -2,500,000 | -100.0% | -0.13% | – | |
| TTPH | Exit | TETRAPHASE PHARMACEUTICALS I | $0 | – | -554,898 | -100.0% | -0.18% | – |
| VCRA | Exit | VOCERA COMMUNICATIONS INC | $0 | – | -273,858 | -100.0% | -0.19% | – |
| ATRC | Exit | ATRICURE INC | $0 | – | -630,000 | -100.0% | -0.28% | – |
| ANTH | Exit | ANTHERA PHARMACEUTICALS INC | $0 | – | -13,893,465 | -100.0% | -0.30% | – |
| MDRX | Exit | ALLSCRIPTS HEALTHCARE SOLUTN | $0 | – | -619,360 | -100.0% | -0.38% | – |
| ARAY | Exit | ACCURAY INC | $0 | – | -1,420,000 | -100.0% | -0.38% | – |
| SGEN | Exit | SEATTLE GENETICS INCput | $0 | – | -300,000 | -100.0% | -0.44% | – |
| IART | Exit | INTEGRA LIFESCIENCES HLDGS C | $0 | – | -258,044 | -100.0% | -0.45% | – |
| ACHN | Exit | ACHILLION PHARMACEUTICALS IN | $0 | – | -1,629,833 | -100.0% | -0.63% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -247,000 | -100.0% | -0.65% | – |
| HUM | Exit | HUMANA INC | $0 | – | -188,000 | -100.0% | -0.75% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -1,067,115 | -100.0% | -0.91% | – |
| HCA | Exit | HCA HOLDINGS INC | $0 | – | -553,020 | -100.0% | -0.94% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -306,018 | -100.0% | -0.97% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -1,779,622 | -100.0% | -0.97% | – |
| HTWR | Exit | HEARTWARE INTL INC | $0 | – | -225,167 | -100.0% | -1.01% | – |
| STJ | Exit | ST JUDE MED INC | $0 | – | -525,000 | -100.0% | -1.13% | – |
| CTRX | Exit | CATAMARAN CORPcall | $0 | – | -550,000 | -100.0% | -1.26% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -2,939,741 | -100.0% | -1.60% | – |
| OPTR | Exit | OPTIMER PHARMACEUTICALS INC | $0 | – | -3,025,829 | -100.0% | -2.06% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.